StoneX Group’s Zomedica Corp. ZOM Stock Holding History

StoneX Group’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,000	Closed	-$2.4K	–	1034
2024 Q4	$2.4K	Sell	20,000 -2,891	-13%	-$364	﹤0.01%	839
2024 Q3	$3.14K	Buy	22,891 +2,891	+14%	+$406	﹤0.01%	648
2024 Q2	$2.92K	Hold	20,000	–	–	﹤0.01%	638
2024 Q1	$2.92K	Sell	20,000 -1,600	-7%	-$224	﹤0.01%	617
2023 Q4	$4.32K	Buy	21,600 +1,600	+8%	+$281	﹤0.01%	577
2023 Q3	$3.34K	Hold	20,000	–	–	﹤0.01%	608
2023 Q2	$4K	Hold	20,000	–	–	﹤0.01%	588
2023 Q1	$4.23K	Hold	20,000	–	–	﹤0.01%	627
2022 Q4	$3.26K	Hold	20,000	–	–	﹤0.01%	619
2022 Q3	$4.22K	Sell	20,000 -4,925	-20%	-$1.3K	﹤0.01%	518
2022 Q2	$5.49K	Buy	24,925 +4,925	+25%	+$1.25K	﹤0.01%	689
2022 Q1	$6.74K	Hold	20,000	–	–	﹤0.01%	612
2021 Q4	$6.13K	Hold	20,000	–	–	﹤0.01%	574
2021 Q3	$10K	Hold	20,000	–	–	﹤0.01%	466
2021 Q2	$17K	Hold	20,000	–	–	﹤0.01%	471
2021 Q1	$32K	Buy	+20,000	New	+$32.7K	0.01%	412

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

JWM

Jackson Wealth Management Lake Mary, Florida $170M AUM 21.01% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

StoneX Group's ZOM Position: Q1 2025 in Review

StoneX Group sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 20,000 shares — an estimated $2.4K sold.

StoneX Group first reported a position in ZOM in Q1 2021 and held it in 16 quarters. The position peaked at $32K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

StoneX Group reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
StoneX Group sold 20,000 Zomedica Corp. shares in Q1 2025, an estimated $2.4K.
StoneX Group first reported a position in Zomedica Corp. in Q1 2021 and held it in 16 quarters.
StoneX Group's Zomedica Corp. position peaked at $32K in Q1 2021.
23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on StoneX Group's 13F filing for Q1 2025, filed 15 May 2025.